spacer
home > white papers > Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan - Sepha Limited
WHITE PAPERS
logo_Sepha_Limi4.jpg

Sepha Limited

phone +44 (0)2890 484848
email info@sepha.com
web http://www.sepha.com
email Unit 25 Carrowreagh Business Park, Carrowreagh Road, Dundonald, Belfast BT16 1QQ

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Medovate announces distribution agreement with LTR Medical for sales of SAFIRAŽ in Australia and New Zealand

08 September 2020: Medovate, the medical device development company, has concluded a distribution agreement with Brisbane-based LTR Medical which will provide exclusivity for SAFIRAŽ (SAFer Injection for Regional Anaesthesia) in Australia and New Zealand.
More info >>


White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>


Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement